Narcolepsy Drugs Market Stakeholders With Covid-19 Impact Analysis: Top Industry Trends & Segments Forecast 2021-2030

Narcolepsy Drugs Industry

The increase in number of patients suffering from sleep disorders further fuels the growth of the global narcolepsy drugs market.

PORTLAND, OR, UNITED STATES, October 20, 2021 / -- Narcolepsy is a chronic disabling condition with symptoms such as cataplexy, excessive daytime sleepiness (EDS), sleep paralysis, hypnogogic hallucinations, and disrupted nocturnal sleep. Most of the narcolepsy drugs are used to treat symptoms related to cataplexy and excessive daytime sleepiness.

The narcolepsy drugs market was valued at $ 2,680.06 million in 2020, and is projected to reach $ 6,667.80 million by 2030, registering a CAGR of 9.6% from 2021 to 2030. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.

Covid-19 Scenario:

1) The COVID-19 pandemic is an unprecedented global public health challenge and is anticipated to have a negative impact on the narcolepsy drugs market.

2) The continuous spread of the COVID-19 pandemic and the measures taken by the governments of various countries have affected, and could continue to affect, the businesses, including future disruptions to supply chain and the manufacture or shipment of drug substance and finished drug products.

3) In addition, delays by manufacturers or their partners in the initiation or enrollment of patients in clinical trials, discontinuations by patients enrolled in clinical trials, difficulties launching or commercializing products and other related activities, which could delay ongoing clinical trials, increase development costs, reduce royalty revenues and have a material adverse effect on manufacturers’ business, financial condition and results of operations.

Download Free Report Sample @

The narcolepsy drugs market size has witnessed significant growth in the past few years. The growth in awareness regarding the health benefits of narcolepsy drug superfood among consumers and a wide variety of natural colors produced by narcolepsy drug contribute toward the market growth. Drug development for narcolepsy treatment has gained incredible momentum the past few years. In addition, governments of countries such as India and South Africa are promoting the production of narcolepsy drug considering its health benefits, which is further expected to boost the narcolepsy drugs market growth during the forecast period. However, lower stability and poor sustainability of natural colors derived from narcolepsy drug as compared to synthetic colors and stringent government regulations are projected to hamper the market growth during the forecast period. Conversely, untapped markets in the developing countries are expected to offer remunerative opportunities for the market players in the near future.

Based on narcolepsy disease type, the narcolepsy drugs market is segmented into daytime extreme sleepiness, cataplexia, and others. Daytime extreme sleepiness segment is the highest revenue generator in the overall narcolepsy drugs market, as large number of people suffering from narcolepsy and other sleep disorders have a higher risk of this symptom, thus increasing the demand for narcolepsy drugs. However, the cataplexia segment is expected to grow at the highest rate, as patients suffering from cataplexia experience loss of muscle control, and almost 70% of narcolepsy patients are found to have this symptom.

Based on therapeutics type, the narcolepsy drugs market is segmented into central nervous system stimulants, tricyclic antidepressants, sodium oxybate, selective serotonin reuptake inhibitor, and others. The sodium oxybate segment held the highest share global narcolepsy drugs market in the 2018, as these drugs are highly effective to treat daytime extreme sleepiness and cataplexy. However, selective serotonin reuptake inhibitor segment is expected to grow at the highest rate due to increase in R&D activities for the development of these type of drugs by the key players.

Inquire before buying @

The Major Key Players Are:

Arena Pharmaceuticals, Inc., Bioprojet Company, Graymark Healthcare, Inc., Hikma Pharmaceuticals PLC, Jazz Pharmaceuticals plc., Ligand Pharmaceuticals Incorporated, Shionogi Inc., Takeda Pharmaceutical Company Limited, Novartis International AG, and Teva Pharmaceutical Industries

Key Findings of the Narcolepsy Drugs Market:

• By disease type, the daytime extreme sleepiness segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
• By therapeutic type, the sodium oxybate segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
• By region, Asia-Pacific is expected to experience market growth at the highest rate during the forecast period.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Laboratory Andrology Equipment Market Analysis, Industry Forecast, 2030

Homeopathy (Homeopathic Medicine) Market Analysis, Industry Forecast, 2030

Laser Cancer Therapy Market Analysis, Industry Forecast, 2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media: